{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:51:47Z","timestamp":1773103907139,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Agency for the Safety of Medicines and Health Products\u2014ANSM"},{"DOI":"10.13039\/100008656","name":"Finovi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Foundation of France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Geriatric Medicine Society\u2014SFGG"},{"name":"French Infectious Diseases Society\u2014SPILF"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amoxicillin\/clavulanic acid (AMX\/CLV) is commonly prescribed in older adults. Because oral and intravenous (IV) routes may be compromised by swallowing disorders or poor venous access, subcutaneous (SC) administration of AMX\/CLV could be an alternative. The main objective of this study was to compare the bioavailability of AMX and CLV after IV and SC administration in older patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This prospective multicentre study enrolled patients aged over 65\u2005y receiving SC or IV AMX\/CLV (1\u2005g\/0.2\u2005g\/8\u2005h). At steady state, AMX and CLV concentrations were measured just before and after the infusion, at 2\u2005h (in the SC group only) and at 5\u2005h using liquid chromatography coupled to tandem mass spectrometry. Population PK analysis estimated SC AMX\/CLV bioavailability in comparison to IV administration and tolerance was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen patients (mean age 85.1\u200a\u00b1\u200a4.8\u2005y) were enrolled (14 in the IV group and three in the SC group). SC bioavailability of AMX and CLV was estimated at 78% and 82%, respectively. Although Cmax values were \u223c45% lower with SC administration, unbound AMX concentrations remained above thresholds for common pathogens (i.e. Streptococcus pneumoniae, Enterococci and Enterobacterales) and trough concentrations were close to those observed after IV administration. On the basis of safety assessment after 122 IV and SC infusions, no serious adverse event related to the treatment occurred and local SC adverse events were transient oedema, erythema and pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study provides data supporting the use of SC administration of AMX\/CLV in the older population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf381","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:10:08Z","timestamp":1762913408000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of subcutaneous amoxicillin\/clavulanic acid pharmacokinetics as an alternative to the intravenous route in older patients\u2014the PhASAge Study"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-3757","authenticated-orcid":false,"given":"Nicolas","family":"Gr\u00e9goire","sequence":"first","affiliation":[{"name":"CHU de Poitiers, Laboratoire de toxicologie-pharmacocin\u00e9tique , Poitiers ,","place":["France"]},{"name":"Univ. Poitiers, UFR M\u00e9decine Pharmacie, INSERM U1070 PHAR2 , Poitiers ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mbarga","sequence":"additional","affiliation":[{"name":"CHU de Poitiers, Laboratoire de toxicologie-pharmacocin\u00e9tique , Poitiers ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Mirfendereski","sequence":"additional","affiliation":[{"name":"Univ. Poitiers, UFR M\u00e9decine Pharmacie, INSERM U1070 PHAR2 , Poitiers ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Stanke-Labesque","sequence":"additional","affiliation":[{"name":"HP2 Laboratory, Univ. Grenoble-Alpes, INSERM U1300\u2014service de Pharmacologie-Pharmacog\u00e9n\u00e9tique-Toxicologie-Grenoble CHU Grenoble\u2014Alpes , Grenoble ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Breilh","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacocin\u00e9tique et de Pharmacie Clinique, Univ. Bordeaux, INSERM U1034 Groupe PK\/PD\u2014CHU Bordeaux, Service de Coordination Pharmacie Clinique Ville-H\u00f4pital , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Forestier","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Metropole Savoie, service de maladies infectieuses , Chamb\u00e9ry ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[{"name":"Laboratoire de Biom\u00e9trie et Biologie Evolutive, Hospices Civils de Lyon, Reference Centre for the Management of Complex Bone and Joint Infection (CRIOAc Lyon)\u2014Univ. Lyon, Univ Claude Bernard Lyon 1, UMR CNRS 5558 , Villeurbanne ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Goutelle","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, GH Nord, H\u00f4pital de la Croix-Rousse, Service de Pharmacie, Lyon ,","place":["France"]},{"name":"UMR CNRS 5558, Laboratoire de Biom\u00e9trie et Biologie Evolutive, Univ Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Villeurbanne ,","place":["France"]},{"name":"Facult\u00e9 de Pharmacie de Lyon, Univ Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Lyon ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Gavazzi","sequence":"additional","affiliation":[{"name":"CHU Grenoble - Alpes, Service Universitaire de G\u00e9riatrie Clinique\u2014Univ. Grenoble-Alpes, T-Raig, TIMC-IMAG, CNRS 5525 , Grenoble ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Brunet","sequence":"additional","affiliation":[{"name":"CHU de Poitiers, p\u00f4le de g\u00e9riatrie , Poitiers ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Paccalin","sequence":"additional","affiliation":[{"name":"CHU de Poitiers, p\u00f4le de g\u00e9riatrie , Poitiers ,","place":["France"]},{"name":"Univ. Poitiers, UFR de M\u00e9decine Pharmacie INSERM, Clinical Investigation Center CIC1402 , Poitiers ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-0979","authenticated-orcid":false,"given":"Claire","family":"Roubaud-Baudron","sequence":"additional","affiliation":[{"name":"CHU Bordeaux, P\u00f4le de G\u00e9rontologie Clinique , Bordeaux ,","place":["France"]},{"name":"Univ. Bordeaux, INSERM UMR 1312 BRIC Bordeaux Institute of Oncology , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Infectiology and Geriatrics InterGroup (SPILF-SFGG GInGer)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Albaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Hyernart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Meriglier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Bronnimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Clabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Domergue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lartigau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Pavese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyprien","family":"Arlaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Froidure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"le Marechal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Drevet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Bioteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Pouderoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Chabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Gaujard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"de la Gastine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"Leperre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youri","family":"Chauleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Lanfranchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Schir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Gueremy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexie","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Destrem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaux","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2026011413271291900_dkaf381-B1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/jgs.14731","article-title":"Geriatric infectious diseases: current concepts on diagnosis and management","volume":"65","author":"Yoshikawa","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"2026011413271291900_dkaf381-B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cmi.2014.08.018","article-title":"Special considerations of antibiotic prescription in the geriatric population","volume":"21","author":"Beckett","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2026011413271291900_dkaf381-B3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jamda.2020.04.035","article-title":"Subcutaneous antibiotic therapy: the why, how, which drugs and when","volume":"22","author":"Hern\u00e1ndez-Ruiz","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"2026011413271291900_dkaf381-B4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/NAN.0000000000000511","article-title":"International consensus recommendation guidelines for subcutaneous infusions of hydration and medication in adults: an e-Delphi Consensus Study","volume":"46","author":"Broadhurst","year":"2023","journal-title":"J Infus Nurs"},{"key":"2026011413271291900_dkaf381-B5","doi-asserted-by":"publisher","first-page":"370.e1","DOI":"10.1016\/j.cmi.2014.11.017","article-title":"Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks","volume":"21","author":"Forestier","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2026011413271291900_dkaf381-B6","author":"Mesples"},{"key":"2026011413271291900_dkaf381-B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40271-014-0075-y","article-title":"Intravenous versus subcutaneous drug administration. Which do patients prefer? A systematic review","volume":"8","author":"Stoner","year":"2014","journal-title":"Patient"},{"key":"2026011413271291900_dkaf381-B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ageing\/afw143","article-title":"Tolerance of subcutaneously administered antibiotics: a French national prospective study","volume":"46","author":"Roubaud-Baudron","year":"2017","journal-title":"Age Ageing"},{"key":"2026011413271291900_dkaf381-B9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2125.1996.03967.x","article-title":"Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers","volume":"42","author":"Champoux","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"2026011413271291900_dkaf381-B10","doi-asserted-by":"publisher","first-page":"ofaf313","DOI":"10.1093\/ofid\/ofaf313","article-title":"Pharmacokinetics of subcutaneous and intravenous ceftriaxone in older population, the PhASAge Study","volume":"12","author":"Roubaud-Baudron","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026011413271291900_dkaf381-B11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00228-008-0493-7","article-title":"How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach","volume":"64","author":"Ogungbenro","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"2026011413271291900_dkaf381-B12","author":"MonolixSuite"},{"key":"2026011413271291900_dkaf381-B13","author":"EUCAST"},{"key":"2026011413271291900_dkaf381-B14","author":"Laboratoire GlaxoSmithKline"},{"key":"2026011413271291900_dkaf381-B15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2125.1986.tb05172.x","article-title":"Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers","volume":"21","author":"Sjovall","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"2026011413271291900_dkaf381-B16","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/biomedicines11061633","article-title":"Pharmacokinetics of antibacterial agents in the elderly: the body of evidence","volume":"11","author":"Butranova","year":"2023","journal-title":"Biomedicines"},{"key":"2026011413271291900_dkaf381-B17","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/jac\/dkw226","article-title":"Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints","volume":"71","author":"de Velde","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2026011413271291900_dkaf381-B18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/AAC.11.1.132","article-title":"Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration","volume":"11","author":"Spyker","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413271291900_dkaf381-B19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cmi.2019.11.028","article-title":"Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage","volume":"26","author":"Huttner","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2026011413271291900_dkaf381-B20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/jac\/dkx376","article-title":"Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis","volume":"73","author":"De Velde","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf381\/65272979\/dkaf381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf381\/65272979\/dkaf381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:27:16Z","timestamp":1768415236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkaf381\/8321380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf381","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,12]]},"article-number":"dkaf381"}}